Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.955
Delayed Data
As of 11:57am ET
 +0.015 / +1.60%
Today’s Change
0.82
Today|||52-Week Range
2.90
-24.21%
Year-to-Date
No recent news for Aveo Pharmaceuticals Inc.

Today’s Trading

Previous close0.94
Today’s open0.95
Day’s range0.93 - 0.96
Volume79,454
Average volume (3 months)200,222
Market cap$54.7M
Dividend yield--
Data as of 11:57am ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)+73.27%
Earnings growth (this year)-101.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.97%
P/E ratioNM
Price/Sales3.69
Price/Book3.17

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd-0.02-2.52%
IMMYImprimis Pharmaceuti...-0.07-1.75%
AVIRAviragen Therapeutic...-0.02-1.37%
MTEXMannatech Inc-0.16-0.77%
Data as of 12:05pm ET, 05/31/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$19.0M
Annual profit (last year)-$15.0M
Net profit margin-78.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs